Skip to main content

Advertisement

SpringerLink
Log in

Unexpected matrix diseases and novel therapeutic strategies

  • Review
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

Within the framework of a broad definition of the extracellular matrix (ECM), this review discusses three genetic disorders in which major pathogenetic features have been traced back to alterations in the levels/activities of matrix components. In each case, disease-associated alterations are found both intra- and extracellularly. The nature of the ECM involvement is surprising, offers an exciting therapeutic opportunity, and deepens our understanding of ECM-cell interactions. The first of these disorders, cherubism, is a case of inflammatory bone loss in the jaws of children for reasons that are surprisingly systemic in nature, considering the local nature of the disease. The primary defect involves an intracellular signaling molecule, but a major pathogenetic component and therapeutic target of the disease is the extracellular cytokine tumor necrosis factor alpha. The second disorder, Knobloch syndrome, is caused by recessive mutations in collagen XVIII. Although this protein has been classified as belonging to a group of structural macromolecules, the consequence of the mutations is impairment of cellular metabolism. The third disorder, infantile hemangioma, is a common tumor of capillary endothelial cells in infancy. The tumor appears within a few days/weeks after birth, grows rapidly over several months, and regresses over several years. The proliferative phase is the result of constitutively high levels of vascular endothelial cell growth factor (VEGF)-dependent signaling through VEGF receptor 2 (VEGFR2), but recent studies have led to the surprising conclusion that abnormalities in a cell-surface receptor complex controlling expression of the VEGF decoy receptor VEGFR1 is the underlying cause.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, Ostrowski MC, Olsen BR, Glimcher LH (2008) NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest 118:3775–3789

    Article  CAS  PubMed  Google Scholar 

  • Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, Mattioli E, Gualandi F, Ferlini A, Merlini L, Maraldi NM, Bonaldo P, Bernardi P (2007) Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci USA 104:991–996

    Article  CAS  PubMed  Google Scholar 

  • Barnes CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, Guo Y, Yu Y, Ingber DE, Mulliken JB, Beggs AH, Folkman J, Fishman SJ (2005) Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 102:19097–19102

    Article  CAS  PubMed  Google Scholar 

  • Bellucci C, Lilli C, Baroni T, Parnetti L, Sorbi S, Emiliani C, Lumare E, Calabresi P, Balloni S, Bodo M (2007) Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer’s disease. Mol Med 13:542–550

    Article  CAS  PubMed  Google Scholar 

  • Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729–733

    Article  CAS  PubMed  Google Scholar 

  • Blei F, Walter J, Orlow SJ, Marchuk DA (1998) Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 134:718–722 [erratum in Arch Dermatol 134:1425]

    Article  CAS  PubMed  Google Scholar 

  • Boon LM, MacDonald DM, Mulliken JB (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104:1616–1623

    Article  CAS  PubMed  Google Scholar 

  • Boye E, Olsen BR (2009) Signaling mechanisms in infantile hemangioma. Curr Opin Hematol 16:202–208

    Article  PubMed  Google Scholar 

  • Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J (2001) Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745–752

    Article  CAS  PubMed  Google Scholar 

  • Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149–160

    Article  CAS  PubMed  Google Scholar 

  • Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA (2001) Identification of the cellular receptor for anthrax toxin. Nature 414:225–229

    Article  CAS  PubMed  Google Scholar 

  • Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537–3545

    Article  CAS  PubMed  Google Scholar 

  • Chen R, Gao B, Huang C, Olsen B, Rotundo RF, Blumenstock F, Saba TM (2000) Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-alpha. Am J Physiol Lung Cell Mol Physiol 279:L161–L174

    CAS  PubMed  Google Scholar 

  • Chen CC, Young JL, Monzon RI, Chen N, Todorovic V, Lau LF (2007) Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J 26:1257–1267

    Article  CAS  PubMed  Google Scholar 

  • Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu GQ, Tesseur I, Wyss-Coray T, Bonaldo P, Mucke L (2009) Collagen VI protects neurons against Abeta toxicity. Nat Neurosci 12:119–121

    Article  CAS  PubMed  Google Scholar 

  • Chiller KG, Passaro D, Frieden IJ (2002) Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 138:1567–1576

    Article  PubMed  Google Scholar 

  • Cicchetti P, Mayer BJ, Thiel G, Baltimore D (1992) Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257:803–806

    Article  CAS  PubMed  Google Scholar 

  • Clark IM, Swingler TE, Sampieri CL, Edwards DR (2008) The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 40:1362–1378

    Article  CAS  PubMed  Google Scholar 

  • Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A (1996) Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591–604

    Article  CAS  PubMed  Google Scholar 

  • Deckert M, Tartare-Deckert S, Hernandez J, Rottapel R, Altman A (1998) Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity 9:595–605

    Article  CAS  PubMed  Google Scholar 

  • Dong S, Cole GJ, Halfter W (2003) Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J Biol Chem 278:1700–1707

    Article  CAS  PubMed  Google Scholar 

  • Duh EJ, Yao YG, Dagli M, Goldberg MF (2004) Persistence of fetal vasculature in a patient with Knobloch syndrome: potential role for endostatin in fetal vascular remodeling of the eye. Ophthalmology 111:1885–1888

    PubMed  Google Scholar 

  • Enjolras O, Breviere GM, Roger G, Tovi M, Pellegrino B, Varotti E, Soupre V, Picard A, Leverger G (2004) Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 11:99–107

    Article  CAS  PubMed  Google Scholar 

  • Ezekowitz RA, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456–1463

    CAS  PubMed  Google Scholar 

  • Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C (2009) Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta (in press)

  • Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC (2004) Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 57:168–171

    Article  CAS  PubMed  Google Scholar 

  • Foucault I, Liu YC, Bernard A, Deckert M (2003) The chaperone protein 14–3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. J Biol Chem 278:7146–7153

    Article  CAS  PubMed  Google Scholar 

  • Foucault I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M (2005) The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood 105:1106–1113

    Article  CAS  PubMed  Google Scholar 

  • Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Li E, Pihlajaniemi T, Olsen BR (2002) Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J 21:1535–1544

    Article  CAS  PubMed  Google Scholar 

  • Gao B, Curtis TM, Blumenstock FA, Minnear FL, Saba TM (2000) Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor. J Cell Sci 113:247–257

    CAS  PubMed  Google Scholar 

  • Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117–121

    Article  CAS  PubMed  Google Scholar 

  • Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150:291–294

    Article  PubMed  Google Scholar 

  • Halfter W, Dong S, Schurer B, Cole GJ (1998) Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273:25404–25412

    Article  CAS  PubMed  Google Scholar 

  • Hidano A, Nakajima S (1972) Earliest features of the strawberry mark in the newborn. Br J Dermatol 87:138–144

    Article  CAS  PubMed  Google Scholar 

  • Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, Terman BI (2005) TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 305:133–144

    Article  CAS  PubMed  Google Scholar 

  • Imai Y, Kanno K, Moriya T, Kayano S, Seino H, Matsubara Y, Yamada A (2003) A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J 40:632–638

    Article  PubMed  Google Scholar 

  • Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236–1246

    Article  CAS  PubMed  Google Scholar 

  • Jones WA (1933) Familial multilocular cystic disease of the jaws. Am J Cancer 17:946–950

    Google Scholar 

  • Knobloch WH, Layer JM (1972) Clefting syndromes associated with retinal detachment. Am J Ophthalmol 73:517–530

    CAS  PubMed  Google Scholar 

  • Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45–53

    Article  CAS  PubMed  Google Scholar 

  • Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651

    Article  CAS  PubMed  Google Scholar 

  • Li CY, Yu SF (2006) A novel mutation in the SH3BP2 gene causes cherubism: case report. BMC Med Genet 7:84

    Article  PubMed  CAS  Google Scholar 

  • Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA (2006) Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat 27:717–718

    Article  PubMed  Google Scholar 

  • Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, Eklund L, Boon LM, Vikkula M (2009) Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 41:118–124

    Article  CAS  PubMed  Google Scholar 

  • Lo B, Faiyaz-Ul-Haque M, Kennedy S, Aviv R, Tsui LC, Teebi AS (2003) Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism. Am J Med Genet 121A:37–40

    Article  PubMed  Google Scholar 

  • Mangion J, Rahman N, Edkins S, Barfoot R, Nguyen T, Sigurdsson A, Townend JV, Fitzpatrick DR, Flanagan AM, Stratton MR (1999) The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet 65:151–157

    Article  CAS  PubMed  Google Scholar 

  • Marneros AG, Olsen BR (2003) Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome. IOVS 44:2367–2372

    Google Scholar 

  • Marneros AG, Keene DR, Hansen U, Fukai N, Moulton K, Goletz PL, Moiseyev G, Pawlyk BS, Halfter W, Dong S, Shibata M, Li T, Crouch RK, Bruckner P, Olsen BR (2004) Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J 23:89–99

    Article  CAS  PubMed  Google Scholar 

  • Marneros AG, She H, Zambarakji H, Hashizume H, Connoly EJ, Kim I, Gragoudas ES, Miller JW, Olsen BR (2007) Endogenous endostatin inhibits choroidal neovascularization. FASEB J 21:3809–3818

    Article  CAS  PubMed  Google Scholar 

  • Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, Loeys B, Huso DL, McDonnell NB, Van Eyk JE, Dietz HC (2009) Circulating transforming growth factor-beta in Marfan syndrome. Circulation 120:526–532

    Article  CAS  PubMed  Google Scholar 

  • Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A, Ferlini A, Maraldi NM, Bonaldo P, Bernardi P (2008) Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 105:5225–5229

    Article  CAS  PubMed  Google Scholar 

  • Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422

    Article  CAS  PubMed  Google Scholar 

  • Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quertermous T, Olsen BR (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci USA 92:8763–8767

    Article  CAS  PubMed  Google Scholar 

  • Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B (2004) TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res 64:817–820

    Article  CAS  PubMed  Google Scholar 

  • North PE, Waner M, Mizeracki A, Mihm MC Jr (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11–22

    Article  CAS  PubMed  Google Scholar 

  • North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC Jr (2001) A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559–570

    CAS  PubMed  Google Scholar 

  • O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285

    Article  PubMed  Google Scholar 

  • Olsen BR (2006) From the editor’s desk. Matrix Biol 25:269–270

    Article  CAS  Google Scholar 

  • Olsen BR (2007) From the editor’s desk. Matrix Biol 26:145

    Article  CAS  Google Scholar 

  • Osada Y, Hashimoto T, Nishimura A, Matsuo Y, Wakabayashi T, Iwatsubo T (2005) CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils. J Biol Chem 280:8596–8605

    Article  CAS  PubMed  Google Scholar 

  • Palma E, Tiepolo T, Angelin A, Sabatelli P, Maraldi NM, Basso E, Forte MA, Bernardi P, Bonaldo P (2009) Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Hum Mol Genet 18:2024–2031

    Article  CAS  PubMed  Google Scholar 

  • Read TA, Sorensen DR, Mahesparan R, Enger PO, Timpl R, Olsen BR, Hjelstuen MH, Haraldseth O, Bjerkvig R (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotech 19:29–34

    Article  CAS  Google Scholar 

  • Ren R, Mayer BJ, Cicchetti P, Baltimore D (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157–1161

    Article  CAS  PubMed  Google Scholar 

  • Rehn M, Hintikka E, Pihlajaniemi T (1996) Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32:436–446

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez C, Alcudia JF, Martinez-Gonzalez J, Raposo B, Navarro MA, Badimon L (2008) Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis 196:558–564

    Article  CAS  PubMed  Google Scholar 

  • Rotundo RF, Curtis TM, Shah MD, Gao B, Mastrangelo A, LaFlamme SE, Saba TM (2002) TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin. Am J Physiol Lung Cell Mol Physiol 282:L316–L329

    CAS  PubMed  Google Scholar 

  • Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998a) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 153:611–626

    CAS  PubMed  Google Scholar 

  • Saarela J, Ylikarppa R, Rehn M, Purmonen S, Pihlajaniemi T (1998b) Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol 16:319–328

    Article  CAS  PubMed  Google Scholar 

  • Sertié AL, Quimby M, Moreira ES, Murray J, Zatz M, Antonarakis SE, Passos-Bueno MR (1996) A gene which causes severe ocular alterations and occipital encephalocele (Knobloch syndrome) is mapped to 21q22.3. Hum Mol Genet 5:843–847

    Article  PubMed  Google Scholar 

  • Sertié AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR (2000) Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure. Hum Mol Genet 9:2051–2058

    Article  PubMed  Google Scholar 

  • Soderberg L, Dahlqvist C, Kakuyama H, Thyberg J, Ito A, Winblad B, Naslund J, Tjernberg LO (2005) Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates. FEBS J 272:2231–2236

    Article  PubMed  CAS  Google Scholar 

  • Suzuki O, Kague E, Bagatini K, Tu H, Heljasvaara R, Carvalhaes L, Gava E, Oliveira G de, Godoi P, Oliva G, Kitten G, Pihlajaniemi T, Passos-Bueno MR (2009) Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome. Mol Vis 15:801–809

    CAS  PubMed  Google Scholar 

  • Tang P, Hung MC, Klostergaard J (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35:8216–8225

    Article  CAS  PubMed  Google Scholar 

  • Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, Finetti F, Braghetta P, Vuagniaux G, Dumont JM, Baldari CT, Bonaldo P, Bernardi P (2009) The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1(-/-) myopathic mice. Br J Pharmacol 157:1045–1052

    Article  CAS  PubMed  Google Scholar 

  • Tiziani V, Reichenberger E, Buzzo CL, Niazi S, Fukai N, Stiller M, Peters H, Salzano FM, Raposo do Amaral CM, Olsen BR (1999) The gene for cherubism maps to chromosome 4p16. Am J Hum Genet 65:158–166

    Article  CAS  PubMed  Google Scholar 

  • Tobinick EL, Gross H (2008) Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer’s disease. BMC Neurol 8:27

    Article  PubMed  CAS  Google Scholar 

  • Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, Ninomiya C, Raposo do Amaral CM, Peters H, Habal M, Rhee-Morris L, Doss JB, Kreiborg S, Olsen BR, Reichenberger E (2001) Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet 28:125–126

    Article  CAS  PubMed  Google Scholar 

  • Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, Saheki Y, Kawai T, Mukherjee PM, Reichenberger E, Olsen BR (2007) Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice. Cell 128:71–83

    Article  CAS  PubMed  Google Scholar 

  • Vikkula M, Boon LM, Carraway K, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181–1190

    Article  CAS  PubMed  Google Scholar 

  • Werner E, Kowalczyk AP, Faundez V (2006) Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 281:23227–23236

    Article  CAS  PubMed  Google Scholar 

  • Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R, Olsen BR (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18:4414–4423

    Article  CAS  PubMed  Google Scholar 

  • Ylikärppä R, Eklund L, Sormunen R, Utriainen A, Kontiola A, Määttä M, Muona A, Fukai N, Olsen BR, Pihlajaniemi T (2003) Lack of type XVIII collagen results in anterior ocular defects. FASEB J 17:2257–2259

    PubMed  Google Scholar 

  • Zollino M, Di Stefano C, Zampino G, Mastroiacovo P, Wright TJ, Sorge G, Selicorni A, Tenconi R, Zappala A, Battaglia A, Di Rocco M, Palka G, Pallotta R, Altherr MR, Neri G (2000) Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am J Med Genet 94:254–261

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA, 02115, USA

    Claudia Nicolae & Bjorn R. Olsen

Authors
  1. Claudia Nicolae
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bjorn R. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bjorn R. Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nicolae, C., Olsen, B.R. Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res 339, 155–165 (2010). https://doi.org/10.1007/s00441-009-0874-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-009-0874-y

Keywords

Search

Navigation